 |
市场调查报告书
商品编码
1402588
西尼罗河病毒市场：依产品类型、依管理途径、依通路、按地区West Nile Virus Market, By Product Type, By Route of Administration, By Distribution Channel, By Region |
||||||
西尼罗河病毒市场规模预计将从 2023 年的 6.348 亿美元增至 2030 年的 10.978 亿美元，预测期内复合年增长率为 8.1%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年 | 2022年 | 2023年市场规模 | 6.348 亿美元 |
| 实际资料 | 2018-2021 | 预测期 | 2023-2030 |
| 预测期复合年增长率 | 8.10% | 2030年市场规模预测 | 10.978 亿美元 |
西尼罗河病毒 (WNV) 是一种由蚊子传播的疾病，可感染人类、鸟类和其他动物。它于 1937 年首次在乌干达西尼罗河地区被发现，此后已传播到世界其他地区，包括北美、欧洲和亚洲。该病毒主要透过受感染的蚊子叮咬传播给人类。西尼罗河病毒可引起多种症状，从轻微的类流感症状到严重的神经系统疾病，如脑炎和脑膜炎。大多数感染者不会表现出任何症状，但约 20% 的人可能会发烧、头痛、身体疼痛、噁心、呕吐和皮疹。在极少数情况下，西尼罗河病毒可能致命。
市场动态：
全球西尼罗河病毒市场受到多种因素的推动。西尼罗河病毒感染发生率的上升，特别是在北美和欧洲，是市场成长的主要驱动力之一。此外，提高对该疾病及其预防和诊断的认识也有助于市场扩张。例如，根据美国疾病管制与预防中心（CDC）的资料，向国家监测系统报告的西尼罗病毒神经侵袭性疾病病例将从2021年的2000多例增加到2022年的2500多例。 。做过。德克萨斯州、加利福尼亚州、路易斯安那州、内布拉斯加州和伊利诺伊州等州的病例数量最多。该病毒的传播可能是由于气候变迁引起的气温升高、感染季节延长以及传播病毒的蚊子的地理范围扩大所致。
然而，也存在阻碍市场成长的因素。对抗西尼罗河病毒的一个主要挑战是有效治疗方法和疫苗的供应有限。与诊断和治疗相关的高成本进一步阻碍了市场成长。
儘管面临这些挑战，市场参与企业仍有机会找到前进的道路。新兴经济体的高成长潜力、有效治疗方法方法的开发以及蚊虫控制方法的更多利用带来了巨大的成长机会。製药公司和研究机构之间的合作还可以加速西尼罗河病毒创新解决方案的发展。
本研究的主要特点
- 该报告对全球西尼罗河病毒市场进行了详细分析，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（CAGR%）。
- 它还阐明了不同细分市场的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
- 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
- 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球西尼罗河病毒市场的主要企业。
- 该报告的见解使行销人员和经营团队负责人就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
- 本研究报告针对该产业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
- 相关人员可以透过用于分析全球西尼罗病毒市场的各种策略矩阵来促进他们的决策。
目录
第一章 研究目的与前提
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章市场动态、法规及趋势分析
- 市场动态
- 影响分析
- 主要亮点
- 监管场景
- 产品发布/核准
- 流行病学
- PEST分析
- 波特的分析
- 併购场景
第四章全球西尼罗河病毒市场－冠状病毒（COVID-19）大流行的影响
- 新型冠状病毒感染疾病（COVID-19）的流行病学
- 供需面分析
- 经济影响
第五章全球西尼罗河病毒市场，依产品类型，2018-2030
- 抗病毒药物
- 疫苗
- 抗生素
- 止痛药
- 其他的
第六章 全球西尼罗河病毒市场，依管理途径，2018-2030 年
- 口服
- 可注射的
- 局部的
第七章 全球西尼罗河病毒市场，依通路，2018-2030
- 医院药房
- 零售药房
- 网路药房
第八章全球西尼罗河病毒市场，按地区，2018-2030
- 北美洲
- 美国
- 加拿大
- 欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 俄罗斯
- 其他欧洲国家
- 亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- ASEAN
- 亚太地区其他国家
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
- 中东
- 2018-2030 年市场规模与按产品类型预测、与前一年同期比较成长率
- 2018-2030 年市场规模与按管理途径预测、与前一年同期比较成长率
- 2018-2030年按通路分類的市场规模与预测、与前一年同期比较成长率
- 2018-2030 年市场规模及各国预测、与前一年同期比较成长率
- GCC
- 以色列
- 其他中东地区
- 非洲
- 2018-2030 年市场规模与按产品类型预测、与前一年同期比较成长率
- 2018-2030 年市场规模与按管理途径预测、与前一年同期比较成长率
- 2018-2030年按通路分類的市场规模与预测、与前一年同期比较成长率
- 2018-2030年按国家/地区与前一年同期比较成长率
- 南非
- 北非
- 中部非洲
第9章 竞争形势
- Sanofi
- Pfizer
- GlaxoSmithKline
- Merck
- AstraZeneca
- Johnson & Johnson
- F.Hoffmann-La Roche
- Novartis
- Cipla
- Gilead Sciences
第10章
- 调查方法
- 关于出版商
The West Nile virus market size is expected to reach US$$ 1,097.8 Mn by 2030, from US$ 634.8 million in 2023, at a CAGR of 8.1% during the forecast period.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2022 | Market Size in 2023: | US$ 634.8 Mn |
| Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: | 8.10% | 2030 Value Projection: | US$ 1,097.8 Mn |
West Nile virus (WNV) is a mosquito-borne disease that affects humans, birds, and other animals. It was first identified in the West Nile region of Uganda in 1937 and has since spread to many parts of the world, including North America, Europe, and Asia. The virus is primarily transmitted to humans through the bite of infected mosquitoes. WNV can cause a range of symptoms, from mild flu-like illness to severe neurologic diseases such as encephalitis and meningitis. While most infected individuals do not develop any symptoms, around 20% may experience fever, headache, body aches, nausea, vomiting, and rash. In rare cases, WNV can be fatal.
Market Dynamics:
The global West Nile virus market is driven by various factors. The rising incidence of WNV infections, especially in North America and Europe, is one of the primary drivers of market growth. Increasing awareness about the disease, its prevention, and diagnostics is also contributing to market expansion. For instance, according to data from the Centers for Disease Control and Prevention (CDC), the number of West Nile virus neuroinvasive disease cases reported to the national surveillance system increased from over 2000 cases in 2021 to over 2500 cases in 2022. States such as Texas, California, Louisiana, Nebraska, and Illinois witnessed the highest number of cases. The growing prevalence of the virus can be attributed to rising temperatures linked to climate change that are extending the transmission season and expanding the geographical range of mosquitoes that can spread the virus.
However, there are certain restraints hampering the growth of the market. The limited availability of effective treatments and vaccines is a major challenge in combating WNV. High costs associated with diagnosis and treatment further hinder market growth.
Despite these challenges, there are opportunities for market players to capitalize on. High growth potential in emerging economies, development of effective treatment options and rising usage of mosquito control methods presents a significant opportunity for growth. In addition, collaborations between pharmaceutical companies and research institutes can accelerate the development of innovative solutions for WNV.
Key features of the study:
- This report provides in-depth analysis of the global West Nile virus market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global West Nile virus market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Sanofi, Pfizer, GlaxoSmithKline, Merck, AstraZeneca, Johnson & Johnson, F. Hoffmann-La Roche, Novartis, Cipla, and Gilead Sciences
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global West Nile virus market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global West Nile virus market
Detailed Segmentation:
- By Product Type:
- Antivirals
- Vaccines
- Antibiotics
- Analgesics
- Others (Immunoglobulins and among Others)
- By Route of Administration:
- Oral
- Injectable
- Topical
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Company Profiles:
- Sanofi
- Pfizer
- GlaxoSmithKline
- Merck
- AstraZeneca
- Johnson & Johnson
- F.Hoffmann-La Roche
- Novartis
- Cipla
- Gilead Scienes
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global West Nile Virus Market, By Product Type
- Global West Nile Virus Market, By Route of Administration
- Global West Nile Virus Market, By Distribution Channel
- Global West Nile Virus Market, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- Epidemiology
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global West Nile Virus Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global West Nile Virus Market, By Product Type, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Antivirals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
- Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
- Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
- Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
6. Global West Nile Virus Market, By Route of Administration , 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
- Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,( US$ Mn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,( US$ Mn)
7. Global West Nile Virus Market, By Distribution Channel, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
8. Global West Nile Virus Market, By Region, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2018 -2030
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
- Germany
- U.K.
- France
- Spain
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Mn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GlaxoSmithKline
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Merck
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- F.Hoffmann-La Roche
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Novartis
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cipla
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Gilead Sciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
10. Section
- Research Methodology
- About us
